Reciprocal interaction between two cellular proteins, Purα and YB-1, modulates transcriptional activity of JCV(CY) in glial cells

Molecular and Cellular Biology

Volumn 19, Issue 4, 1999, Pages 2712-2723

  Safak, Mahmut ^a   Gallia, Gary L ^a   Khalili, Kamel ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PUR ALPHA PROTEIN; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

ARTICLE; DNA SEQUENCE; GLIA CELL; HUMAN; HUMAN CELL; JC VIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EUKARYOTA; JC VIRUS; POLYOMAVIRUS;

EID: 0032964375     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.4.2712     Document Type: Article

References (52)

1. E: identification of a novel activator domain located upstream from the 98 bp enhancer region. Nucleic Acids Res. 18; 7417-7423.
2. E, in vitro. J. Biol. Chem. 265:13899-13905.
3. Asakuno, K., K. Kohno, T. Uchiumi, T. Kubo, S. Sato, M. Isono, and M. Kuwano. 1994. Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D. Biochem. Biophys. Res. Commun. 199:1428-1435.
4. Ausubel, F., R. Brent, R. E. Kingston, D. D. Moar, J. G. Siedman, J. A. Smith, and K. Struhl. 1989. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
5. Bargou, R. C., K. Jurchott, C. Wagener, S. Bergmann, S. Metzner, K. Bommert, M. Y. Mapara, K. J. Winzer, M. Dietel, B. Dorken, and H. D. Royer. 1997. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression, Nat. Med. 3:447-450.
6. Bayarsaihan, D., B. Enkhmandakh, and L. N. Lukens. 1996. Y-box proteins interact with the S1 nuclease-sensitive site in the chicken alpha 2(I) collagen gene promoter. Biochem. J. 319:203-207.
7. Bengal, E., L. Ransone, R. Scharfmann, V. J. Dwarki, S. J. Tapscott, H. Weintraub, and I. M. Verma. 1992. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 68:507-519.
8. Berger, J. R., and M. Concha. 1995. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J. Neurovirol. 1:5-18.
9. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
10. Chang, C.-F., H. Tada, and K. Khalili. 1994. The role of a pentanucleotide repeat sequence, AGGGAAGGGA, in the regulation of JC virus DNA replication. Gene 148:309-314.
11. Chen, N. N., and K. Khalili. 1995. Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Purα in glial cells. J. Virol. 69:5843-5848.
12. Chen, N. N., C.-F. Chang, G. L. Gallia, D. A. Kerr, E. M. Johnson, C. P. Krachmarov, S. M. Barr, R. J. Frisque, B. Bollag, and K. Khalili. 1995. Cooperative action of cellular proteins YB-1 and Purα with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc. Natl. Acad. Sci. USA 92:1087-1091.
13. Chepenik, L. G., A. P. Tretiakova, C. P. Krachmarov, E. M. Johnson, and K. Khalili. 1998. The single-stranded DNA binding protein, Purα, binds HIV-1 TAR RNA and activates HIV-1 transcription. Gene 210:37-44.
14. Chesters, P. M., J. Heritage, and D. J. McCance. 1983. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissue. J. Infect. Dis. 147:676-684.
15. Dörries, K. 1984. Progressive multifocal leukoencephalopathy: analysis of JC virus DNA from brain and kidney tissue. Virus Res. 1:25-38.
16. Feigenbaum, L., S. H. Hinrichs, and G. Jay. 1992. JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice. J. Virol. 66:1176-1182.
17. Frisque, R. J., and F. A. White III. 1992. The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy, p. 25-158. In R. P. Roos (ed.), Molecular neurovirology. Humana Press, Totowa, N.J.
18. Frisque, R. J., G. L. Bream, and M. T. Cannella. 1984. Human polyomavirus JC virus genome. J. Virol. 51:458-469.
19. Gallia, G. L., M. Safak, and K. Khalili. 1998. Interaction of single-stranded DNA binding protein, Purα, with human polyomavirus, JCV, early protein, T-antigen. J. Biol. Chem. 273:32662-32669.
20. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
21. Graham, F. L., and A. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-457.
22. Grinnell, B. W., B. L. Padgett, and D. L. Walker. 1983. Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoencephalopathy. J. Infect. Dis. 147:669-675.
23. Haas, S., N. S. Haque, A. H. Beggs, K. Khalili, R. L. Knobler, and J. A. Small. 1995. Expression of the myelin basic protein gene in transgenic mice expressing human neurotropic virus, JCV, early protein. Virology 202:89-96.
24. Johnson, E. M., P. L. Chen, C. P. Krachmarov, S. M. Barr, M. Kanovsky, Z. W. Ma, and W. H. Lee. 1995. Association of human Purα with the retinoblastoma protein, Rb, regulates binding to the single-stranded DNA Purα recognition element. J. Biol. Chem. 41:24352-24360.
25. Kenney, S., V. Natarajan, V. Strika, G. Khoury, and N. P. Salzman. 1984. JC virus enhancer-promoter active in human brain cells. Science 226:1337-1339.
26. Kerr, D., C.-F. Chang, N. N. Chen, G. Gallia, G. Raj, B. Schwartz, and K. Khalili. 1994. Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of JC viral late gene. J. Virol. 68:7637-7643.
27. Krachmarov, C. P., L.G. Chepenik, S. M. Barr, K. Khalili, and E. M. Johnson. 1996. Association of the HIV-1 Tat protein with human cellular protein, Purα, enhances binding of Purα to the JC virus Tat-responsive transcriptional control element. Proc. Natl. Acad. Sci. USA 93:14112-14117.
28. Li, W. W., Y. Hsiung, V. Wong, K. Galvin, Y. Zhou, Y. Shi, and A. S. Lee. 1997. Suppression of grp78 core promoter element-mediated stress induction by the dbpA and dbpB (YB-1) cold shock domain proteins. Mol. Cell. Biol. 17:61-68.
29. Luckow, B., and G. Schultz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490-5498.
30. Lynch, K. J., and R. J. Frisque. 1990. Identification of critical elements within the JC virus DNA replication origin. J. Virol. 64:5812-5822.
31. MacDonald, G. H., Y. Itoh-Lindstrom, and J. P. Ting. 1995. The transcriptional regulatory protein, YB-1, promotes single-stranded regions in the DRA promoter. J. Biol. Chem. 270:3527-3533.
32. Major, E. O., K. Amemiya, C. Tornatore, S. A. Houff, and J. R. Berger. 1992. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 5:49-73.
33. McCance, D. J. 1983. Persistence of animal and human papovaviruses in renal and nervous tissues, p. 343-357. In J. L. Sever and D. L. Madden (ed.). Polyomaviruses and human neurological diseases. Alan R. Liss, New York, N.Y.
34. Mertens, P. R., S. Harendza, A. S. Pollock, and D. H. Lovett. 1997. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J. Biol. Chem. 272:22905-22912.
35. Montani, V., S. I. Taniguchi, M. Shong, K. Suzuki, M. Ohmori, C. Giuliani, G. Napolitano, M. Saji, B. Fiorentino, A. M. Reimold, J. P. Ting, L. D. Kohn, and D. S. Singer. 1998. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein. Endocrinology 139:280-289.
36. Muralidharan, V., A. Tretiakova, A. Steplewski, S. Haas, E. Johnson, and K. Khalili. 1997. Evidence for inhibition of MyEF-2 binding to MBP promoter by MEF-1/Pur α. J. Cell. Biochem. 66:524-531.
37. Ohmori, M., H. Shimura, Y. Shimura, and L. D. Kohn. 1996. A Y-box protein is a suppressor factor that decreases thyrotropin receptor gene expression. Mol. Endocrinol. 10:76-89.
38. Raj, G., and K. Khalili. 1995. Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 213:283-291.
39. Raj, G., M. Safak, G. MacDonald, and K. Khalili. 1996. Transcriptional regulation of human polyomavirus JCV: evidence for a functional interaction between ReIA (p65) and the Y-box binding protein. J. Virol. 70:5944-5953.
40. Shaknovich, R., G. Shue, and D. S. Kohtz. 1992. Conformational activation of a basic helix-loop-helix protein (MyoD1) by the C-terminal region of murine HSP90 (HSP84). Mol. Cell. Biol. 12:5059-5068.
41. Small, J. A., G. A. Scangos, L. Cork, G. Jay, and G. Khoury. 1986. The early region of human papovaviruses JC induces dysmyelination in transgenic mice. Cell 46:13-18.
42. Stein, B., A. S. Baldwin, Jr., D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated function. EMBO J. 12:3879-3891.
43. Stein, B., P. C. Cogswell, and A. S. Baldwin, Jr. 1993. Functional and physical association between NF-kappa B and C/EBP family member: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13:3964-3974.
44. Tada, H., and K. Khalili. 1992. A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus. J. Virol. 66:6885-6892.
45. L promoter function: evidence that a pentanucleotide "silencer" repeat sequence, AGG GAAGGGA, down-regulates transcription of the JC virus late promoter. Virology 180:327-338.
46. Tada, H., M. Lashgari, J. Rappaport, and K. Khalili. 1989. Cell-type specific expression of JC virus early promoter is determined by positive and negative regulation. J. Virol. 63:463-466.
47. Thatikunta, P., B. E. Sawaya, L. Denisova, C. Cole, G. Yusibora, E. M. Johnson, K. Khalili, and S. Amini. 1997. Identification of a cellular protein that binds to Tat-responsive element of TGFβ-1 promoter in glial cells. J. Cell. Biochem. 67:466-477.
48. Ting, J. P., A. Painter, N. J. Zeleznik-Le, G. MacDonald, T. M. Moore, A. Brown, and B. D. Schwartz. 1994. YB-1 DNA-hinding protein represses interferon gamma activation of class II major histocompatibility complex gene. J. Exp. Med. 179:1605-1611.
49. Yogo, Y., T. Kitamura, C. Sugimoto, T. Ueki, Y. Aso, K. Hara, and F. Taguchi. 1990. Isolation of a possible archetypal JC virus DNA sequence from nonimmunocomprised individuals. J. Virol. 64:3139-3143.
50. Zambrano, N., S. DeRenzis, G. Minopoli, R. Faraonio, V. Donini, A. Scaloni, F. Cimino, and T. Russo. 1997. DNA-binding protein Purα and transcription factor YY1 function as transcription activators of the neuron-specific FE65 gene promoter. Biochem. J. 328:293-300.
51. Zoltick, P. W., R. Reddy, C.-F. Chang, B. Northrup, K. Khalili, and R. J. Schwartzman. 1995. Isolation and characterization of a type II human neurotropic JC virus from a brain biopsy of a patient with progressive multifocal leukoencephalopathy. J. Neurovirol. 1:307-315.
52. Zou, Y., and K. R. Chien. 1995. EF1A/YB-1 is a component of cardiac HF-1A binding activity and positively regulates transcription of the myosin light-chain 2v gene. Mol. Cell. Biol. 15:2972-2982.